Global Generic Drug CRO (Contract Research Organisation) 麻豆原创 Research Report 2024

Publication ID:

PB508246965

Publication Date:

August 26, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

CRO (Contract Research Organization) is a company that provides support to the pharmaceutical, biotechnology, and medical device industries in the form of research services outsourced on a contract basis. A CRO may provide such services as biopharmaceutical development, biological assay development, commercialization, clinical development, clinical trials management, pharmacovigilance, outcomes research, and real world evidence.
Generic drug CRO is a CRO company that provides generic drug development services. In terms of generic drugs, CRO companies mainly provide services such as pharmaceutical research (raw material research, preparation research), clinical BE trials, and registration and marketing.
The global Generic Drug CRO (Contract Research Organisation) market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Generic Drug CRO (Contract Research Organisation) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Generic Drug CRO (Contract Research Organisation) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Generic Drug CRO (Contract Research Organisation) in Pharmaceutical Companies is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Generic Drug CRO (Contract Research Organisation) include Worldwide Clinical Trials, Eurofins Scientific, Celerion, Alliance Pharma, Accelsiors, Innovind Pharma, Avivia, SUNNOVO and Hangzhou Bio-Sincerity Pharma-Tech, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Generic Drug CRO (Contract Research Organisation), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Generic Drug CRO (Contract Research Organisation).
Report Scope
The Generic Drug CRO (Contract Research Organisation) market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Generic Drug CRO (Contract Research Organisation) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Generic Drug CRO (Contract Research Organisation) companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
麻豆原创 Segmentation
By Company
Worldwide Clinical Trials
Eurofins Scientific
Celerion
Alliance Pharma
Accelsiors
Innovind Pharma
Avivia
SUNNOVO
Hangzhou Bio-Sincerity Pharma-Tech
Wanbang Biopharma
Guangzhou Boji Medical & Biotechnological
Xinjiang Bai Hua Cun Pharma Tech
Shandong Bestcomm Pharmaceutical
Segment by Type
Pharmaceutical Research
BE Test
Segment by Application
Pharmaceutical Companies
MAH Customer
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Generic Drug CRO (Contract Research Organisation) companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global Generic Drug CRO (Contract Research Organisation) 麻豆原创 Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Pharmaceutical Research
1.2.3 BE Test
1.3 麻豆原创 by Application
1.3.1 Global Generic Drug CRO (Contract Research Organisation) 麻豆原创 Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Pharmaceutical Companies
1.3.3 MAH Customer
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Generic Drug CRO (Contract Research Organisation) 麻豆原创 Perspective (2019-2030)
2.2 Generic Drug CRO (Contract Research Organisation) Growth Trends by Region
2.2.1 Global Generic Drug CRO (Contract Research Organisation) 麻豆原创 Size by Region: 2019 VS 2023 VS 2030
2.2.2 Generic Drug CRO (Contract Research Organisation) Historic 麻豆原创 Size by Region (2019-2024)
2.2.3 Generic Drug CRO (Contract Research Organisation) Forecasted 麻豆原创 Size by Region (2025-2030)
2.3 Generic Drug CRO (Contract Research Organisation) 麻豆原创 Dynamics
2.3.1 Generic Drug CRO (Contract Research Organisation) Industry Trends
2.3.2 Generic Drug CRO (Contract Research Organisation) 麻豆原创 Drivers
2.3.3 Generic Drug CRO (Contract Research Organisation) 麻豆原创 Challenges
2.3.4 Generic Drug CRO (Contract Research Organisation) 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Top Generic Drug CRO (Contract Research Organisation) Players by Revenue
3.1.1 Global Top Generic Drug CRO (Contract Research Organisation) Players by Revenue (2019-2024)
3.1.2 Global Generic Drug CRO (Contract Research Organisation) Revenue 麻豆原创 Share by Players (2019-2024)
3.2 Global Generic Drug CRO (Contract Research Organisation) 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Generic Drug CRO (Contract Research Organisation) Revenue
3.4 Global Generic Drug CRO (Contract Research Organisation) 麻豆原创 Concentration Ratio
3.4.1 Global Generic Drug CRO (Contract Research Organisation) 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Generic Drug CRO (Contract Research Organisation) Revenue in 2023
3.5 Generic Drug CRO (Contract Research Organisation) Key Players Head office and Area Served
3.6 Key Players Generic Drug CRO (Contract Research Organisation) Product Solution and Service
3.7 Date of Enter into Generic Drug CRO (Contract Research Organisation) 麻豆原创
3.8 Mergers & Acquisitions, Expansion Plans
4 Generic Drug CRO (Contract Research Organisation) Breakdown Data by Type
4.1 Global Generic Drug CRO (Contract Research Organisation) Historic 麻豆原创 Size by Type (2019-2024)
4.2 Global Generic Drug CRO (Contract Research Organisation) Forecasted 麻豆原创 Size by Type (2025-2030)
5 Generic Drug CRO (Contract Research Organisation) Breakdown Data by Application
5.1 Global Generic Drug CRO (Contract Research Organisation) Historic 麻豆原创 Size by Application (2019-2024)
5.2 Global Generic Drug CRO (Contract Research Organisation) Forecasted 麻豆原创 Size by Application (2025-2030)
6 North America
6.1 North America Generic Drug CRO (Contract Research Organisation) 麻豆原创 Size (2019-2030)
6.2 North America Generic Drug CRO (Contract Research Organisation) 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Generic Drug CRO (Contract Research Organisation) 麻豆原创 Size by Country (2019-2024)
6.4 North America Generic Drug CRO (Contract Research Organisation) 麻豆原创 Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Generic Drug CRO (Contract Research Organisation) 麻豆原创 Size (2019-2030)
7.2 Europe Generic Drug CRO (Contract Research Organisation) 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Generic Drug CRO (Contract Research Organisation) 麻豆原创 Size by Country (2019-2024)
7.4 Europe Generic Drug CRO (Contract Research Organisation) 麻豆原创 Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Generic Drug CRO (Contract Research Organisation) 麻豆原创 Size (2019-2030)
8.2 Asia-Pacific Generic Drug CRO (Contract Research Organisation) 麻豆原创 Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Generic Drug CRO (Contract Research Organisation) 麻豆原创 Size by Region (2019-2024)
8.4 Asia-Pacific Generic Drug CRO (Contract Research Organisation) 麻豆原创 Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Generic Drug CRO (Contract Research Organisation) 麻豆原创 Size (2019-2030)
9.2 Latin America Generic Drug CRO (Contract Research Organisation) 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Generic Drug CRO (Contract Research Organisation) 麻豆原创 Size by Country (2019-2024)
9.4 Latin America Generic Drug CRO (Contract Research Organisation) 麻豆原创 Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Generic Drug CRO (Contract Research Organisation) 麻豆原创 Size (2019-2030)
10.2 Middle East & Africa Generic Drug CRO (Contract Research Organisation) 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Generic Drug CRO (Contract Research Organisation) 麻豆原创 Size by Country (2019-2024)
10.4 Middle East & Africa Generic Drug CRO (Contract Research Organisation) 麻豆原创 Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Worldwide Clinical Trials
11.1.1 Worldwide Clinical Trials Company Detail
11.1.2 Worldwide Clinical Trials Business Overview
11.1.3 Worldwide Clinical Trials Generic Drug CRO (Contract Research Organisation) Introduction
11.1.4 Worldwide Clinical Trials Revenue in Generic Drug CRO (Contract Research Organisation) Business (2019-2024)
11.1.5 Worldwide Clinical Trials Recent Development
11.2 Eurofins Scientific
11.2.1 Eurofins Scientific Company Detail
11.2.2 Eurofins Scientific Business Overview
11.2.3 Eurofins Scientific Generic Drug CRO (Contract Research Organisation) Introduction
11.2.4 Eurofins Scientific Revenue in Generic Drug CRO (Contract Research Organisation) Business (2019-2024)
11.2.5 Eurofins Scientific Recent Development
11.3 Celerion
11.3.1 Celerion Company Detail
11.3.2 Celerion Business Overview
11.3.3 Celerion Generic Drug CRO (Contract Research Organisation) Introduction
11.3.4 Celerion Revenue in Generic Drug CRO (Contract Research Organisation) Business (2019-2024)
11.3.5 Celerion Recent Development
11.4 Alliance Pharma
11.4.1 Alliance Pharma Company Detail
11.4.2 Alliance Pharma Business Overview
11.4.3 Alliance Pharma Generic Drug CRO (Contract Research Organisation) Introduction
11.4.4 Alliance Pharma Revenue in Generic Drug CRO (Contract Research Organisation) Business (2019-2024)
11.4.5 Alliance Pharma Recent Development
11.5 Accelsiors
11.5.1 Accelsiors Company Detail
11.5.2 Accelsiors Business Overview
11.5.3 Accelsiors Generic Drug CRO (Contract Research Organisation) Introduction
11.5.4 Accelsiors Revenue in Generic Drug CRO (Contract Research Organisation) Business (2019-2024)
11.5.5 Accelsiors Recent Development
11.6 Innovind Pharma
11.6.1 Innovind Pharma Company Detail
11.6.2 Innovind Pharma Business Overview
11.6.3 Innovind Pharma Generic Drug CRO (Contract Research Organisation) Introduction
11.6.4 Innovind Pharma Revenue in Generic Drug CRO (Contract Research Organisation) Business (2019-2024)
11.6.5 Innovind Pharma Recent Development
11.7 Avivia
11.7.1 Avivia Company Detail
11.7.2 Avivia Business Overview
11.7.3 Avivia Generic Drug CRO (Contract Research Organisation) Introduction
11.7.4 Avivia Revenue in Generic Drug CRO (Contract Research Organisation) Business (2019-2024)
11.7.5 Avivia Recent Development
11.8 SUNNOVO
11.8.1 SUNNOVO Company Detail
11.8.2 SUNNOVO Business Overview
11.8.3 SUNNOVO Generic Drug CRO (Contract Research Organisation) Introduction
11.8.4 SUNNOVO Revenue in Generic Drug CRO (Contract Research Organisation) Business (2019-2024)
11.8.5 SUNNOVO Recent Development
11.9 Hangzhou Bio-Sincerity Pharma-Tech
11.9.1 Hangzhou Bio-Sincerity Pharma-Tech Company Detail
11.9.2 Hangzhou Bio-Sincerity Pharma-Tech Business Overview
11.9.3 Hangzhou Bio-Sincerity Pharma-Tech Generic Drug CRO (Contract Research Organisation) Introduction
11.9.4 Hangzhou Bio-Sincerity Pharma-Tech Revenue in Generic Drug CRO (Contract Research Organisation) Business (2019-2024)
11.9.5 Hangzhou Bio-Sincerity Pharma-Tech Recent Development
11.10 Wanbang Biopharma
11.10.1 Wanbang Biopharma Company Detail
11.10.2 Wanbang Biopharma Business Overview
11.10.3 Wanbang Biopharma Generic Drug CRO (Contract Research Organisation) Introduction
11.10.4 Wanbang Biopharma Revenue in Generic Drug CRO (Contract Research Organisation) Business (2019-2024)
11.10.5 Wanbang Biopharma Recent Development
11.11 Guangzhou Boji Medical & Biotechnological
11.11.1 Guangzhou Boji Medical & Biotechnological Company Detail
11.11.2 Guangzhou Boji Medical & Biotechnological Business Overview
11.11.3 Guangzhou Boji Medical & Biotechnological Generic Drug CRO (Contract Research Organisation) Introduction
11.11.4 Guangzhou Boji Medical & Biotechnological Revenue in Generic Drug CRO (Contract Research Organisation) Business (2019-2024)
11.11.5 Guangzhou Boji Medical & Biotechnological Recent Development
11.12 Xinjiang Bai Hua Cun Pharma Tech
11.12.1 Xinjiang Bai Hua Cun Pharma Tech Company Detail
11.12.2 Xinjiang Bai Hua Cun Pharma Tech Business Overview
11.12.3 Xinjiang Bai Hua Cun Pharma Tech Generic Drug CRO (Contract Research Organisation) Introduction
11.12.4 Xinjiang Bai Hua Cun Pharma Tech Revenue in Generic Drug CRO (Contract Research Organisation) Business (2019-2024)
11.12.5 Xinjiang Bai Hua Cun Pharma Tech Recent Development
11.13 Shandong Bestcomm Pharmaceutical
11.13.1 Shandong Bestcomm Pharmaceutical Company Detail
11.13.2 Shandong Bestcomm Pharmaceutical Business Overview
11.13.3 Shandong Bestcomm Pharmaceutical Generic Drug CRO (Contract Research Organisation) Introduction
11.13.4 Shandong Bestcomm Pharmaceutical Revenue in Generic Drug CRO (Contract Research Organisation) Business (2019-2024)
11.13.5 Shandong Bestcomm Pharmaceutical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

Worldwide Clinical Trials
Eurofins Scientific
Celerion
Alliance Pharma
Accelsiors
Innovind Pharma
Avivia
SUNNOVO
Hangzhou Bio-Sincerity Pharma-Tech
Wanbang Biopharma
Guangzhou Boji Medical & Biotechnological
Xinjiang Bai Hua Cun Pharma Tech
Shandong Bestcomm Pharmaceutical

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.